BTLA(+)CD200(+) B-Cells Dictate the Divergent Immune Landscape and Immunotherapeutic Resistance in Metastatic Versus Primary Pancreatic Cancer-MedSci.cn

BTLA(+)CD200(+) B-Cells Dictate the Divergent Immune Landscape and Immunotherapeutic Resistance in Metastatic Versus Primary Pancreatic Cancer

Diskin, B; Adam, S; Soto, GS; Liria, M; Aykut, B; Sundberg, B; Li, E; Chen, R; Miller, G

ANNALS OF SURGICAL ONCOLOGY, 2020; 27 (SUPPL 1): S126

科室
- - 订阅+
  - 更多科室
工具
服务